Science Explorer Back to mapMap
Discussion
Researcher · Innate Pharma (France) · France

Guillaume Habif

Guillaume Habif publishes mostly in Immunology, Oncology and Hematology, on topics such as Immune Cell Function and Interaction, CAR-T cell therapy research and T-cell and B-cell Immunology.

ORCID 0000-0003-2511-8606 OpenAlex
World rank
#1,554,445
of 7,710,434 ranked researchers
Rank in France
#69,550
of 324,115
Works
23
Citations
2.6k
Citations per work
113.2
h-index
8
i10-index 7Top 85% in Immunology
Guillaume Habif

What does Guillaume Habif research?

Guillaume Habif's work is mostly in Medicine (55%), Immunology and Microbiology (37%).

Health Sciences: 13 works · 54.9% of their workMedicine: 13 works · 54.9% of their workOncology: 5 works · 23.5% of their workHematology: 3 works · 11.8% of their workGenetics: 2 works · 9.8% of their workPathology and Forensic Medicine: 1 works · 5.9% of their workInfectious Diseases: 1 works · 3.9% of their workLife Sciences: 9 works · 37.3% of their workImmunology and Microbiology: 9 works · 37.3% of their workImmunology: 9 works · 37.3% of their workEverything else: 2 works · 7.8% of their workTHEIR WORKGuillaume Habif23works
Life Sciences37%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1354.9%
    1. Immunology and Microbiology937.3%
  3. Everything else27.8%
  1. 1Immunology37% of their works
  2. 2Oncology24% of their works
  3. 3Hematology12% of their works
  4. 4Genetics10% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Infectious Diseases4% of their works

Research topics

Which keywords describe Guillaume Habif's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, CAR T Cells, Chimeric Antigen Receptor, Prognostic Factors, Foxp3, TGF-ß and Acute Myeloid Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. NK Cell Recognition91 topic
  2. Natural Killer Cells91 topic
  3. CAR T Cells81 topic
  4. Chimeric Antigen Receptor81 topic
  5. Prognostic Factors62 topics
  6. Foxp351 topic
  7. TGF-ß51 topic
  8. AML41 topic
  9. Acute Myeloid Leukemia41 topic
  10. BCR-ABL21 topic
  11. Chronic Lymphocytic Leukemia21 topic
  12. Genomic Aberrations21 topic
  13. Imatinib21 topic
  14. Immune Checkpoint Blockade21 topic
  15. JAK2 Mutation21 topic
  16. Myelofibrosis21 topic
  17. PD-1 and PD-L121 topic

Where does Guillaume Habif work?

Guillaume Habif's main affiliation in the publication record is Innate Pharma (France), France.

How many publications and citations does Guillaume Habif have?

OpenAlex counts 23 works and 2,603 citations for Guillaume Habif, an h-index of 8, ranking #1,554,445 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Guillaume Habif. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.